- Home
- / Sinclair Pharma
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Sinclair Pharma financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Revenue
£43.6 M
FY, 2018
CreditSafe Score
?
Score changed on Jun 14, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| GBP | FY, 2016 | FY, 2017 | FY, 2018 |
|---|---|---|---|
| Revenue | 45.5M | 45.3M | 43.6M |
| Revenue growth, % | -0.4% | -3.8% | |
| Cost of goods sold | 13.7M | 12.4M | 13.3M |
| Gross profit | 31.8M | 32.9M | 30.3M |
| Gross profit margin, % | 69.9% | 72.6% | 69.6% |
| Operating expense total | 50.1M | 35.0M | 68.9M |
| EBITDA | (11.0M) | 3.3M | (32.8M) |
| EBITDA margin, % | -24.2% | 7.2% | -75.3% |
| EBIT | (18.2M) | (2.2M) | (38.6M) |
| EBIT margin, % | -40.1% | -4.8% | -88.5% |
| Pre tax profit | (34.0M) | (4.3M) | (49.7M) |
| Income tax expense | (634.0K) | (3.7M) | (178.0K) |
| Net Income | (33.4M) | (674.0K) | (49.5M) |